BARD1 and cancer: BRCA1 associated RING domain 1 (BARD1) has often been thought of as a tumor suppressor gene, but recent studies have caused some to re-evaluate its cancer-related role as being oncogenic instead, with the gene having potential as a therapeutic target for cancer susceptibility and testing.39